Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Epizyme discovers first orally bioavailable SMYD3 inhibitor EPZ-031686

Dec. 11, 2015

Fluorescent tumor imaging achieved with BLZ-100 in phase I glioma trial

Dec. 11, 2015

Novel optimized human FVIII vector SPK-8005 demonstrates therapeutic utility in hemophilia

Dec. 11, 2015

Experimental cardiac arrest and resuscitation uses aged animals

Dec. 10, 2015

Technique devised for imaging platelets in thrombosis models

Dec. 10, 2015

Eli Lilly presents clinical results for emibetuzumab

Dec. 10, 2015

Novel Ras inhibitors from ADT Pharmaceuticals suppress tumor growth in vivo

Dec. 10, 2015

Imetelstat shows promise for refractory anemia

Dec. 10, 2015

IL-15N72D/IL-15Ralpha-Fc superagonist complex shows promise for high-risk hematologic malignancies

Dec. 9, 2015

First clinical results show feasibility of first-in-class HGF/VEGF inhibitor MP-0250 in oncology

Dec. 9, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...